alexa Abstract | Virtual screening against Mycobacterium tuberculosis isocitrate lyase and in silico ADME-Tox evaluation of Top Hits

Journal of Chemical and Pharmaceutical Research
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Original Articles Open Access

Abstract

Isocitrate lyase (ICL) is a key factor for the maintenance of latent tuberculosis infection. ICL catalyses the first committed step of the carbon-conserving glyoxylate bypass, the reversible cleavage of isocitrate into succinate and glyoxylate. Since Mycobacterium tuberculosis(MTb) has no back-up mechanism that can take over the role of ICL once it is inhibited, the ICL enzyme is an attractive target for inhibition and discovery of anti-TB drugs. Structurebased pharmacophore generation has beenused here in virtual screening of database compounds andde novo evolution method was employed in subsequent hit optimization. Accordingly, the strucutre of ICL was modeled and a pharmacophore was generated based on the structure of the binding site. Subsequent pharmacophore-based screening of one million compounds yielded 17 hits with greater binding energies than that of the natural substrate. The derivative of each hit showed even much stronger binding affinities. Both set of original and modified hit compounds were evaluatedin silico for their ADME-Tox properties. The results showed that Ligands O (242372) and P (Amb9999830), and derivatives ofD (Compound2099M), E (Compound3796M), K (Compound556M), N (STOCK1N-12208M), and P (Amb9999830M) possess promising drug-like properties and can be pursued as leads in the search for novel antitubercular agents.

To read the full article Peer-reviewed Article PDF image

Author(s): Nina Abigail B Clavio and Junie B Billones

Keywords

Mycobacterium tuberculosis, anti-tuberculosis compounds, isocitrate lyase, pharmacophore, ADMET, TOPKAT, computer-aided drug discovery, Mycobacterium

 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords